An underground economy for unapproved slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.
Investigational Drug Gaining Popularity Via Social Media
Retatrutide, which remains in research studies, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are urged to message these accounts directly for source information, while also receiving discount codes.
Active Trade on Social Networks
Additionally, a robust market exists on messaging services, where communities with numerous of members share “before and after” images, injection guides and assertions of rapid British shipping. Vendors market the substance there before directing buyers to WhatsApp for transactions.
Learning About Retatrutide
This medication is an experimental injection created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist patients lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Healthcare Experts Voice Concerns
However, doctors and chemists have cautions that the sale of what remains an unapproved drug in the United Kingdom is worrisome and could result in users injecting products of uncertain source.
Several experts stated the demand for retatrutide could be connected to the rising price of licensed weight loss products such as Mounjaro.
Regulatory Position and Enforcement
Marketing retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unapproved medication that cannot be marketed or supplied for human use under the British medical regulations.
Several influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still breach pharmaceutical, advertising, and consumer regulations, risking penalties, prosecution or prison.
Service Response and Material Removal
Based on the social media company, the platform has removed violative material and prohibited associated hashtags and search suggestions. The company stated it was committed to keeping the service secure and allocating resources in enhancing compliance measures.
Online Trading Activities
Investigations also found groups with up to 9,000 members selling retatrutide using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately brings up channels with thousands of users, populated with photos of slimming results, glowing reviews and detailed guides for mixing or administering at home.
Within minutes of entering one group, a seller posted WhatsApp details, where most transactions occur. The seller provided an instruction manual and promised delivery within 48 hours. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one asked about weight, health issues or past usage.
Item Details and Costs
Within these groups, posts display dark colored parcels with postal service stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at home with purified liquid, or ready-to-use injectors typically priced at 160 pounds for 20mg. When questioned how long a pen should last, sellers give contradictory answers varying between a several days to “depends on your body”.
Platform Moderation and Safety Measures
A spokesperson for Telegram stated it regularly monitored harmful content on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are administering substances they can’t verify. Although the science behind this drug is valid, these online products may not contain what they advertise,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.
A medical professional of an online medical service linked the increase in demand to current price rises for approved slimming medications such as Mounjaro. “With costs rising, patients are using social media. But fake treatments are extremely risky. You cannot know what’s contained or whether the conditions they were made in was clean,” she said.
Her team has previously seen individuals harmed by personal administration from unverified suppliers. “We recognize the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be impure or improperly measured.”
Manufacturer Position
A representative from Eli Lilly stated retatrutide was in third stage research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, adding that any product “falsely representing itself as a Lilly investigational substance not yet authorized … may subject patients to possibly serious medical dangers”.
